Published in Cancer Sci on March 25, 2015
Influence of Equatorial CH⋅⋅⋅O Interactions on Secondary Kinetic Isotope Effects for Methyl Transfer. Angew Chem Int Ed Engl (2016) 0.79
Challenges in detecting pre-malignant pancreatic lesions during acute pancreatitis using a serum microRNA assay: a study based on KrasG12D transgenic mice. Oncotarget (2016) 0.77
Bioinformatic Profiling Identifies a Glucose-Related Risk Signature for the Malignancy of Glioma and the Survival of Patients. Mol Neurobiol (2016) 0.75
Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol (1997) 29.02
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med (2011) 24.32
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med (2013) 16.24
PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis (2004) 4.33
Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci U S A (1995) 4.28
Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proc Natl Acad Sci U S A (2009) 3.08
Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene (2003) 2.96
Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer. J Clin Oncol (2008) 2.04
Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Cancer Res (2001) 1.87
New role for estrogen in cancer? Science (1998) 1.80
Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res (1998) 1.80
Estrogen metabolism by conjugation. J Natl Cancer Inst Monogr (2000) 1.68
Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res (1999) 1.47
Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies. BMC Cancer (2010) 1.36
Variation in the COMT gene: implications for pain perception and pain treatment. Pharmacogenomics (2009) 1.07
Role of cancer stem cells in pancreatic ductal adenocarcinoma. Nat Rev Clin Oncol (2009) 0.99
Predictors of cancer in patients with suspected pancreatic malignancy without a tissue diagnosis. Am J Surg (2006) 0.99
Low efficacy of serum levels of CA 19-9 in prediction of malignant diseases in asymptomatic population in Taiwan. Hepatogastroenterology (2006) 0.97
Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer. Cancer Res (2003) 0.97
Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls. Breast Cancer Res Treat (2009) 0.89
Estrogen-nucleic acid adducts: reaction of 3,4-estrone-o-quinone radical anion with deoxyribonucleosides. Chem Res Toxicol (1997) 0.84
Immunohistochemical localization of catechol methyltransferase in normal and cancerous breast tissues of mice and rats. J Natl Cancer Inst (1983) 0.79
Old and new drugs in systemic therapy of pancreatic cancer. Crit Rev Oncol Hematol (2004) 0.79
A phase I/II, non-randomized, feasibility/safety and efficacy study of the combination of everolimus, cetuximab and capecitabine in patients with advanced pancreatic cancer. Invest New Drugs (2012) 0.79
[The expression of catechol O-methyltransferase gene in colorectal cancer]. Zhonghua Wai Ke Za Zhi (2010) 0.78
Increased COMT expression in pancreatic cancer and correlation with clinicopathologic parameters. Sci China Life Sci (2012) 0.78
Catechol-O-methyltransferase inhibits colorectal cancer cell proliferation and invasion. Arch Med Res (2014) 0.77
[Candidate immunogenic membrane antigens of human pancreatic cancer]. Zhonghua Wai Ke Za Zhi (2010) 0.77
Robotic versus open pancreatectomy: a systematic review and meta-analysis. Ann Surg Oncol (2013) 2.15
The metabolic syndrome and risk factors for biliary tract cancer: a case-control study in China. Asian Pac J Cancer Prev (2012) 0.92
Insulin-like growth factor 1 receptor (IGF-1R) as a target of MiR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancer. PLoS One (2014) 0.88
Metabolic syndrome components and risk factors for pancreatic adenocarcinoma: a case-control study in China. Digestion (2012) 0.84
The effect of pylorus removal on delayed gastric emptying after pancreaticoduodenectomy: a meta-analysis of 2,599 patients. PLoS One (2014) 0.80
miR-497 expression, function and clinical application in cancer. Oncotarget (2016) 0.79
Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis. J Surg Oncol (2016) 0.79
Catechol-O-methyltransferase inhibits colorectal cancer cell proliferation and invasion. Arch Med Res (2014) 0.77
MiR-1178 promotes the proliferation, G1/S transition, migration and invasion of pancreatic cancer cells by targeting CHIP. PLoS One (2015) 0.76
Targeted next-generation sequencing of dedifferentiated chondrosarcoma in the skull base reveals combined TP53 and PTEN mutations with increased proliferation index, an implication for pathogenesis. Oncotarget (2016) 0.75
Reply to 'letter to the editor of Annals of Surgical Oncology concerning "robotic versus open pancreatectomy: a systematic review and meta-analysis",' by Petrucciani Niccolò, et al. (ASO-2013-09-1427). Ann Surg Oncol (2014) 0.75
CHIP: A new modulator of human malignant disorders. Oncotarget (2016) 0.75
Pancreatic cancer progression relies upon mutant p53-induced oncogenic signaling mediated by NOP14. Cancer Res (2017) 0.75